Market Overview:
The global guanidinoacetic acid market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for guanidinoacetic acid in feed and pharmaceutical applications. The other type segment is projected to grow at a higher CAGR than the other application segments during the forecast period. North America is expected to dominate the global guanidinoacetic acid market in terms of revenue, followed by Europe and Asia Pacific.
Product Definition:
Guanidinoacetic acid is a non-proteinogenic amino acid formed from the combination of two molecules of glycine and one molecule of creatine. It is found in small quantities in human urine, where it is thought to play a role in the disposal of excess creatine.
Feed Grade:
Feed grade refers to the quality of feedstock used in the production of guanidinoacetic acid (GAA). It is a key raw material used for manufacturing Alpha-GPC, which is further utilized as a substrate for formulating various pharmaceuticals. The demand and supply gap in terms of volume can be attributed to growing demand from end-use industries such as dietary supplements and nutraceuticals along with an increase in exports.
Pharmaceutical Grade:
Pharmaceutical grade is the purity level of a product and it's used in guanidinoacetic acid market for the preparation of pharmaceutical drugs. Pharmaceutical grade products are manufactured by controlling certain parameters such as pH value, temperature, impurities content, and other chemical components.
The main objective behind controlling these parameters is to maintain the integrity of final product which contains active ingredients.
Application Insights:
The other application segment accounted for the largest revenue share of over 60% in 2017. Other applications include animal feed, pharmaceuticals and cosmetics. The demand for GGNA is expected to increase owing to its use as a raw material in the production of several medicines including paracetamol, aspirin, codeine phosphate and dihydrocodeine phosphate.
Guanidinoacetic acid (GNA) is used as an intermediate chemical in the manufacturing of various products such as paracetamol ( fever reducer & cough suppressant), dihydrocodeine (painkiller) and dimethyl tetracycline (antibacterial). These medicines are widely used across several applications due to their ability to treat different types of diseases with only one dose.
Regional Analysis:
Asia Pacific accounted for the largest share of over 60% in 2017. The region is expected to maintain its dominance during the forecast period owing to high product demand from countries, such as China and India. In addition, increasing meat consumption in these countries is likely to drive industry growth.
China was one of the largest producers and consumers of guanidinoacetic acid across Asia Pacific due to easy availability of raw materials coupled with low manufacturing cost as compared to other regions. However, stringent regulations by Chinese government regarding utilization of animal-based drugs are projectededto hamper market growth over the forecast period.
Growth Factors:
- Increasing demand for Guanidinoacetic Acid in the pharmaceutical and nutraceutical industries as a dietary supplement to improve athletic performance and cognitive function.
- Growing popularity of Guanidinoacetic Acid as a sports nutrition supplement, especially among bodybuilders and athletes.
- Rising awareness about the benefits of Guanidinoacetic Acid among consumers, which is likely to boost demand over the next few years.
- Increasing research on Guanidinoacetic Acid for its potential therapeutic applications in various diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.
Scope Of The Report
Report Attributes
Report Details
Report Title
Guanidinoacetic Acid Market Research Report
By Type
Feed Grade, Pharmaceutical Grade, Other
By Application
Fodder, Medicine, Other
By Companies
Evonik, GENDONE, Hebei Daxiao, Tiancheng Chempharm, Lubon Industry, Hubei Yuanhua, Jiangsu Yuanyang, Shijiazhuang Zexing Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Guanidinoacetic Acid Market Report Segments:
The global Guanidinoacetic Acid market is segmented on the basis of:
Types
Feed Grade, Pharmaceutical Grade, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fodder, Medicine, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Evonik
- GENDONE
- Hebei Daxiao
- Tiancheng Chempharm
- Lubon Industry
- Hubei Yuanhua
- Jiangsu Yuanyang
- Shijiazhuang Zexing Group
Highlights of The Guanidinoacetic Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Feed Grade
- Pharmaceutical Grade
- Other
- By Application:
- Fodder
- Medicine
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Guanidinoacetic Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Guanidinoacetic acid is a molecule that contains a Guanidine group and an Acid group.
Some of the key players operating in the guanidinoacetic acid market are Evonik, GENDONE, Hebei Daxiao, Tiancheng Chempharm, Lubon Industry, Hubei Yuanhua, Jiangsu Yuanyang, Shijiazhuang Zexing Group.
The guanidinoacetic acid market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Guanidinoacetic Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Guanidinoacetic Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Guanidinoacetic Acid Market - Supply Chain
4.5. Global Guanidinoacetic Acid Market Forecast
4.5.1. Guanidinoacetic Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Guanidinoacetic Acid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Guanidinoacetic Acid Market Absolute $ Opportunity
5. Global Guanidinoacetic Acid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Guanidinoacetic Acid Market Size and Volume Forecast by Type
5.3.1. Feed Grade
5.3.2. Pharmaceutical Grade
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Guanidinoacetic Acid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Guanidinoacetic Acid Market Size and Volume Forecast by Application
6.3.1. Fodder
6.3.2. Medicine
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Guanidinoacetic Acid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Guanidinoacetic Acid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Guanidinoacetic Acid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Guanidinoacetic Acid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Guanidinoacetic Acid Demand Share Forecast, 2019-2026
9. North America Guanidinoacetic Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Guanidinoacetic Acid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Guanidinoacetic Acid Market Size and Volume Forecast by Application
9.4.1. Fodder
9.4.2. Medicine
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Guanidinoacetic Acid Market Size and Volume Forecast by Type
9.7.1. Feed Grade
9.7.2. Pharmaceutical Grade
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Guanidinoacetic Acid Demand Share Forecast, 2019-2026
10. Latin America Guanidinoacetic Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Guanidinoacetic Acid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Guanidinoacetic Acid Market Size and Volume Forecast by Application
10.4.1. Fodder
10.4.2. Medicine
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Guanidinoacetic Acid Market Size and Volume Forecast by Type
10.7.1. Feed Grade
10.7.2. Pharmaceutical Grade
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Guanidinoacetic Acid Demand Share Forecast, 2019-2026
11. Europe Guanidinoacetic Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Guanidinoacetic Acid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Guanidinoacetic Acid Market Size and Volume Forecast by Application
11.4.1. Fodder
11.4.2. Medicine
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Guanidinoacetic Acid Market Size and Volume Forecast by Type
11.7.1. Feed Grade
11.7.2. Pharmaceutical Grade
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Guanidinoacetic Acid Demand Share, 2019-2026
12. Asia Pacific Guanidinoacetic Acid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Guanidinoacetic Acid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Guanidinoacetic Acid Market Size and Volume Forecast by Application
12.4.1. Fodder
12.4.2. Medicine
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Guanidinoacetic Acid Market Size and Volume Forecast by Type
12.7.1. Feed Grade
12.7.2. Pharmaceutical Grade
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Guanidinoacetic Acid Demand Share, 2019-2026
13. Middle East & Africa Guanidinoacetic Acid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Guanidinoacetic Acid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Guanidinoacetic Acid Market Size and Volume Forecast by Application
13.4.1. Fodder
13.4.2. Medicine
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Guanidinoacetic Acid Market Size and Volume Forecast by Type
13.7.1. Feed Grade
13.7.2. Pharmaceutical Grade
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Guanidinoacetic Acid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Guanidinoacetic Acid Market: Market Share Analysis
14.2. Guanidinoacetic Acid Distributors and Customers
14.3. Guanidinoacetic Acid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Evonik
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GENDONE
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hebei Daxiao
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Tiancheng Chempharm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lubon Industry
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hubei Yuanhua
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Jiangsu Yuanyang
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shijiazhuang Zexing Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
